Navigace

  • o nás
  • informace
  • pomoc a podpora
  • publikace





drogy-info.cz / English / staff / MUDr. Viktor Mravčík

MUDr. Viktor Mravčík

Head of the focal point
Mravcik_Viktor.JPG
He is the Head of the Czech National Monitoring Centre for Drugs and Drug Addiction (National Focal Point; NFP). He is responsible for management of the National Focal Point and implementation of the drug information system, cooperation with Advisory Committee of the National Drug
Commission in the field of data collection, training of NFP workers and publishing of the Annual Report. In addition, he is responsible for the issues of prevalence estimates of problem use of illicit drugs.
mravcik.viktor-at- vlada.cz

He graduated at the Medical Faculty at Palacky University in Olomouc in 1993. In 1997, he received first-degree attestation in the discipline of hygiene and epidemiology. In the year 2000, he completed extension attestation in the field of epidemiology (Institute for Post-Graduate Education in Medicine, Prague). He completed international courses in the field of epidemiology and drug policy (Portugal, Netherlands).
In 1993 - 2002, he held different positions in the health sector (in the discipline of hygiene and epidemiology). Before he started to work for the Czech National Focal Point, he had been a leader of the Center of Epidemiology at District Hygiene Station in Karviná. He was a member of the Impact Analysis Project of New Drugs Legislation in the Czech Republic (PAD) research team.
Since 2002 he is the Head of the Czech National Monitoring Centre for Drugs and drug Addiction, which is the member of the Reitox network of Focal Points coordinated by EMCDDA. He is a member of editorial board of the Adiktologie journal . In 2002-2004 he was acting as vice-spokesperson of Reitox network. He is involved in numbers of international projects in the area of drug epidemiology and drug policy.
He is the editor and main author of the Czech Annual Report on Drug Situation commissioned by the Czech government and EMCDDA and an author of many expert studies and articles focusing on drug epidemiology and prevalence of infections in risk population groups.

Publikováno: 02.01.2008
Aktualizováno: 15.05.2008